0001104659-15-034712.txt : 20150813 0001104659-15-034712.hdr.sgml : 20150813 20150506123902 ACCESSION NUMBER: 0001104659-15-034712 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NephroGenex, Inc. CENTRAL INDEX KEY: 0001338095 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 3200 BEECHLEAF COURT STREET 2: SUITE 900 CITY: RALEIGH STATE: NC ZIP: 27604 BUSINESS PHONE: (609) 986-1780 MAIL ADDRESS: STREET 1: 3200 BEECHLEAF COURT STREET 2: SUITE 900 CITY: RALEIGH STATE: NC ZIP: 27604 FORMER COMPANY: FORMER CONFORMED NAME: NephroGenex Inc DATE OF NAME CHANGE: 20050907 CORRESP 1 filename1.htm

 

May 6, 2015

 

VIA EDGAR

 

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street N.E.

Washington, D.C.  20549

Attn:  Mara Ransom, Assistant Director

 

Re:                             NephroGenex, Inc. (the “Company”)

Registration Statement on Form S-1 (File No. 333- 203530)

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), Canaccord Genuity Inc. and JMP Securities LLC, as representatives of the several underwriters, hereby join in the request of the Company for the acceleration of the effective date of the above-referenced Registration Statement, so that it will become effective at 5:15 p.m., eastern daylight savings time, on Thursday, May 7, 2015, or as soon thereafter as practicable.

 

We hereby authorize each of Yvan Claude J. Pierre, Esq., William N. Haddad, Esq. and Ryan P. McCarthy, Esq. of Reed Smith LLP, attorneys for the underwriters, to orally modify or withdraw this request for acceleration.

 

Pursuant to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter, who is reasonably anticipated to be invited to participate in the distribution of the securities, as many copies of the preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

 

The undersigned confirm that they have complied with and will continue to comply with, and they have been informed or will be informed by participating dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced issue.

 

[Signatures Follow]

 


 

 

Very truly yours,

 

 

 

CANACCORD GENUITY INC.

 

 

 

 

 

 

By:

/s/ Jennifer E. Pardi

 

 

Name:

Jennifer E. Pardi

 

 

Title:

Managing Director, Equity Capital Markets

 

 

 

 

 

JMP SECURITIES LLC

 

 

 

 

 

 

By:

/s/ Stephen Ortiz

 

 

Name:

Stephen Ortiz

 

 

Title:

Managing Director